Diabetic retinopathy (DR) is a vision-threatening complication of
diabetes mellitus characterized by chronic
retinal microvascular
inflammation. The involvement of CD4+ T cells in
retinal vascular
inflammation has been considered, but the specific subset and mechanism of T cell-mediated response during the process remains unclear. Here, we aim to investigate the potential role of follicular helper T (Tfh) cells, a newly identified subset of CD4+ T cells in
retinal vascular
inflammation in DR. Methods: Patients with DR were enrolled and the PD-1+CXCR5+CD4+ Tfh cells were detected in the peripheral blood by flow cytometry. The
streptozotocin (STZ)-induced DR model and
oxygen-induced retinopathy (OIR) model were established, and 79-6, an inhibitor of Bcl-6, was injected intraperitoneally to suppress Tfh cells. The Tfh cells-related genes were investigated in the spleen, lymph nodes, and retina of mice by flow cytometry, immunofluorescence, and qPCR. Results: The Tfh cells expanded in the circulation of patients with DR and also increased in circulation, lymph nodes and
retinal tissues from the STZ-induced DR mice and OIR mice. Notably, inhibition of Bcl-6, a critical
transcription factor for Tfh cells development, prevented upregulation of Tfh cells and its typical
IL-21 cytokine, and ameliorated vascular leakage in DR mice or
retinal angiogenesis in OIR mice, indicating that Bcl-6-directed Tfh cells could promote vascular
inflammation and angiogenesis. Conclusions: Our results suggested that excessive Bcl-6-directed Tfh cells represent an unrecognized feature of DR and be responsible for the
retinal vascular
inflammation and angiogenesis, providing opportunities for new therapeutic approaches to DR.